Medicine and Dentistry
Abdominal Pain
8%
Adjuvant Chemotherapy
18%
Aneurysm
25%
Angiography
7%
Antithrombotic
25%
Biopsy
8%
Bowel Resection
25%
Cancer
8%
Cancer Surgery
12%
Cell-Free DNA
25%
Chemotherapy
8%
Classical Hodgkin Lymphoma
8%
Colon
8%
Colorectal Cancer
61%
Colorectal Cancer Screening
25%
Common Hepatic Artery
25%
Cross Sectional Study
25%
Diseases
18%
Disseminated Disease
8%
Elective Surgery
18%
Endoscopy
11%
Epstein Barr Virus
16%
Final Diagnosis
8%
Gastrointestinal Bleeding
25%
Gastrointestinal Tract
7%
Hodgkin's Lymphoma
25%
Immunosuppressive Treatment
8%
Malaise
8%
Mercaptopurine
8%
Meta-Analysis
25%
Metastatic Carcinoma
8%
Nutrition Supplement
25%
Occult Blood Test
25%
Omega-3 Fatty Acid
25%
Patient with Crohn's Disease
25%
Patient with Ulcerative Colitis
25%
Pelvis
8%
Postoperative Complication
25%
Promoter Region
16%
Proportional Hazards Model
8%
Rectum Cancer
8%
Recurrent Disease
12%
Sigmoid
8%
Sigmoidectomy
8%
Spontaneous Remission
8%
Stenosis
8%
Supplementation
12%
Surgery
16%
Symptom
11%
Ulcerative Colitis
8%
Keyphrases
5-year Survival
6%
Adjusted Relative Risk
8%
Adjuvant Chemotherapy
9%
Antithrombotic Therapy
25%
Colorectal Cancer
30%
Colorectal Cancer Recurrence
6%
Colorectal Cancer Screening
25%
Colorectal Cancer Staging
6%
Colorectal Cancer Surgery
6%
Disease Risk
6%
DNA Promoter
16%
Fecal Immunochemical Test
25%
Hepatic Artery Aneurysm
25%
Hypermethylated DNA
25%
Hypermethylated Genes
6%
Immunosurveillance
6%
Malaise
6%
Methylation Markers
25%
N-3 FA
25%
Nodular Sclerosis Classical Hodgkin Lymphoma
6%
Non-vitamin K Antagonist Oral Anticoagulants
5%
Omega-3 Fatty Acids
25%
Oncogenic Viruses
6%
Oral nutritional Supplements
12%
Ottawa
6%
Perioperative Care
25%
Positive Predictive Value
8%
Postoperative Complications
6%
Prognostic Efficacy
25%
Rectosigmoid Resection
6%
Recurrent Disease
6%
Repeat Biopsy
6%
Test Positivity
5%
Tumor Aggressiveness
6%
Ulcerative Lesions
6%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
25%
Cancer Recurrence
8%
Chemotherapy
18%
Colorectal Cancer
100%
Cross-Sectional Study
25%
Disease
14%
Metastatic Colorectal Cancer
6%
Nutrition Supplement
25%
Omega-3 Fatty Acid
25%
Overall Survival
6%
Postoperative Complication
12%
Recurrent Disease
12%
Survival Rate
6%